Analyze Diet
Veterinary immunology and immunopathology2016; 173; 10-16; doi: 10.1016/j.vetimm.2016.03.016

Duration of in vivo endotoxin tolerance in horses.

Abstract: Endotoxemia models are used to study mechanisms and treatments of early sepsis. Repeated endotoxin exposures induce periods of endotoxin tolerance, characterized by diminished proinflammatory responses to lipopolysaccharide (LPS) and modulated production of proinflammatory cytokines. Repeated measure designs using equine endotoxemia models are rarely performed, despite the advantages associated with reduced variability, because the altered responsiveness would confound study results and because the duration of equine endotoxin tolerance is unknown. We determined the interval of endotoxin tolerance, in vivo, in horses based on physical, clinicopathologic, and proinflammatory gene expression responses to repeated endotoxin exposures. Six horses received 30 ng/kg LPS in saline infused over 30 min. Behavior pain scores, physical examination parameters, and blood for complete blood count and proinflammatory gene expression were obtained at predetermined intervals for 24h. Horses received a total of 3 endotoxin exposures. The first exposure was LPS 1, followed 7 days later by LPS 7 or 14-21 days later by LPS 14-21. Lipopolysaccharide exposures were allocated in a randomized, crossover design. Lipopolysaccharide produced clinical and clinicopathologic signs of endotoxemia and increased expression of tumor necrosis factor alpha (TNFα), interleukin (IL)-6 and IL-8, P<0.001. Horses exhibited evidence of endotoxin tolerance following LPS 7 but not following LPS 14-21. Horses had significantly lower pain scores, heart rates, respiratory rates and duration of fever, after LPS 7 compared to LPS 1 and LPS 14-21, P<0.001, and expression of TNFα was lower in the whole blood of horses after LPS 7, P=0.05. Clinical parameters and TNFα gene expression were similar or slightly increased in horses following LPS 14-21 compared to measurements made in horses following LPS 1, suggesting that endotoxin tolerance had subsided. A minimum of 3 weeks between experiments is warranted if repeated measures designs are used to assess in vivo response to endotoxin in horses.
Publication Date: 2016-03-30 PubMed ID: 27090620DOI: 10.1016/j.vetimm.2016.03.016Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on gaining a better understanding of endotoxin tolerance in horses. The researchers find that endotoxin tolerance, a reduced inflammatory response to endotoxins, lasts around one week in horses. The finding is important for designing future studies involving repeated testing on horse subjects since a minimum of three weeks should be allowed between experiments to avoid interference from this tolerance effect.

Objective of the Research

  • The study aimed to establish the duration of endotoxin tolerance in horses for the first time. Understanding this duration is vital to the design of repeated measure studies using equine endotoxemia models, as the altered responsiveness from endotoxin tolerance would confound study results.
  • In particular, the researchers sought to measure and compare physical, clinicopathologic, and proinflammatory gene expression responses to repeated endotoxin exposures in horses.

Methodology

  • This study involved six horses, each of which received three endotoxin exposures at different time intervals.
  • Each exposure involved an infusion of lipopolysaccharides (LPS), a component of endotoxin, in saline.
  • Pain scores, physical examination parameters, and blood samples for complete blood count and proinflammatory gene expression were obtained at predetermined intervals for 24 hours following each exposure.
  • The treatments were administered in a randomized, crossover design to permit balanced, comparative analysis of the tolerance effect.

Results

  • The study found that LPS produced clinical and clinicopathologic signs of endotoxemia in horses and increased the expression of certain proinflammatory genes.
  • Following a second exposure to LPS after 7 days, horses exhibited signs of endotoxin tolerance, including significantly lower pain scores, heart rates, respiratory rates, and duration of fever compared to first and last exposures.
  • However, this tolerance seemed to have subsided by the third exposure 14-21 days later, as clinical parameters and gene expression were similar or slightly increased compared to the first exposure. This suggests the tolerance duration does not extend beyond two weeks.

Conclusion

  • The study concludes that horses display an in vivo tolerance to endotoxins which lasts around a week but seems to have waned by two weeks following the initial exposure.
  • From this finding, the researchers suggest that a minimum of three weeks should be allowed between experiments if repeated measures designs are used to evaluate the in vivo response to endotoxin in horses.

Cite This Article

APA
Holcombe SJ, Jacobs CC, Cook VL, Gandy JC, Hauptman JG, Sordillo LM. (2016). Duration of in vivo endotoxin tolerance in horses. Vet Immunol Immunopathol, 173, 10-16. https://doi.org/10.1016/j.vetimm.2016.03.016

Publication

ISSN: 1873-2534
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 173
Pages: 10-16
PII: S0165-2427(16)30041-1

Researcher Affiliations

Holcombe, Susan J
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA. Electronic address: holcomb6@cvm.msu.edu.
Jacobs, Carrie C
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Cook, Vanessa L
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Gandy, Jeffery C
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Hauptman, Joseph G
  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Sordillo, Lorraine M
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.

MeSH Terms

  • Animals
  • Cross-Over Studies
  • Disease Models, Animal
  • Endotoxemia / immunology
  • Endotoxemia / veterinary
  • Endotoxins / administration & dosage
  • Endotoxins / immunology
  • Female
  • Horses / immunology
  • Immune Tolerance
  • Lipopolysaccharides / immunology
  • Male
  • Time Factors

Citations

This article has been cited 10 times.
  1. Mercer MA, Davis JL, McKenzie HC. The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses.. Animals (Basel) 2023 May 10;13(10).
    doi: 10.3390/ani13101597pubmed: 37238029google scholar: lookup
  2. Blangy-Letheule A, Vergnaud A, Dupas T, Rozec B, Lauzier B, Leroux AA. Spontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives.. Cells 2023 Mar 30;12(7).
    doi: 10.3390/cells12071052pubmed: 37048125google scholar: lookup
  3. Mercer MA, Davis JL, McKenzie HC, Messenger KM, Schaefer E, Council-Troche RM, Werre SR. Pharmacokinetics and efficacy of orally administered acetaminophen (paracetamol) in adult horses with experimentally induced endotoxemia.. J Vet Intern Med 2023 Mar;37(2):718-727.
    doi: 10.1111/jvim.16663pubmed: 36840424google scholar: lookup
  4. Mukhopadhyay A, Cook SR, SanMiguel P, Ekenstedt KJ, Taylor SD. TLR4 and MD2 variation among horses with differential TNFα baseline concentrations and response to intravenous lipopolysaccharide infusion.. Sci Rep 2023 Jan 27;13(1):1486.
    doi: 10.1038/s41598-023-27956-ypubmed: 36707633google scholar: lookup
  5. Johnson LM, Holcombe SJ, Shearer TR, Watson V, Gandy J, Southwood LL, Lynch TM, Schroeder EL, Fogle CA, Sordillo LM. Multicenter Placebo-Controlled Randomized Study of Ethyl Pyruvate in Horses Following Surgical Treatment for ≥ 360° Large Colon Volvulus.. Front Vet Sci 2020;7:204.
    doi: 10.3389/fvets.2020.00204pubmed: 32373640google scholar: lookup
  6. Wedn AM, El-Gowilly SM, El-Mas MM. Time and sex dependency of hemodynamic, renal, and survivability effects of endotoxemia in rats.. Saudi Pharm J 2020 Jan;28(1):127-135.
    doi: 10.1016/j.jsps.2019.11.014pubmed: 31933528google scholar: lookup
  7. Kopper JJ, Bolger ME, Kogan CJ, Schott HC 2nd. Outcome and complications in horses administered sterile or non-sterile fluids intravenously.. J Vet Intern Med 2019 Nov;33(6):2739-2745.
    doi: 10.1111/jvim.15631pubmed: 31609037google scholar: lookup
  8. Sheats MK. A Comparative Review of Equine SIRS, Sepsis, and Neutrophils.. Front Vet Sci 2019;6:69.
    doi: 10.3389/fvets.2019.00069pubmed: 30931316google scholar: lookup
  9. Lu W, Gu JY, Zhang YY, Gong DJ, Zhu YM, Sun Y. Tolerance induced by Porphyromonas gingivalis may occur independently of TLR2 and TLR4.. PLoS One 2018;13(7):e0200946.
    doi: 10.1371/journal.pone.0200946pubmed: 30040860google scholar: lookup
  10. Vinther AM, Heegaard PM, Skovgaard K, Buhl R, Andreassen SM, Andersen PH. Characterization and differentiation of equine experimental local and early systemic inflammation by expression responses of inflammation-related genes in peripheral blood leukocytes.. BMC Vet Res 2016 Jun 1;12:83.
    doi: 10.1186/s12917-016-0706-8pubmed: 27250718google scholar: lookup